A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice

Vaccination is an effective strategy to control influenza disease. Adjuvants enhance the efficacy of vaccines, but few adjuvants are approved for human use, so novel, safe, and effective adjuvants are urgently needed. The glycolipid adjuvant 7DW8-5 has shown adjuvanticity to malaria vaccine; however...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Huapeng Feng, Noriko Nakajima, Li Wu, Makoto Yamashita, Tiago J. S. Lopes, Moriya Tsuji, Hideki Hasegawa, Tokiko Watanabe, Yoshihiro Kawaoka
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2019-09-01
Edice:	Frontiers in Microbiology
Témata:	glycolipid 7DW8-5 influenza vaccine adjuvants mice
On-line přístup:	https://www.frontiersin.org/article/10.3389/fmicb.2019.02157/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!